Combined Inhibition of the BMP pathway and the RANK-RANKL axis in a Mixed Lytic/blastic Prostate Cancer Lesion

The purpose of this study was to investigate the influence of combined inhibition of RANKL (receptor activator of nuclear factor kappa-B ligand) and bone morphogenetic protein (BMP) activity in a mixed lytic/blastic prostate cancer lesion in bone. Human prostate cancer cells (C4 2b) were injected in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Virk, Mandeep S., Alaee, Farhang, Petrigliano, Frank A., Sugiyama, Osamu, Chatziioannou, Arion F., Stout, David, Dougall, William C., Lieberman, Jay R.
Format: Artigo
Idioma:Inglês
Publicat: 2010
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3039095/
https://ncbi.nlm.nih.gov/pubmed/21073986
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bone.2010.11.003
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars